health 🧠 Jolly Healthcare drops KETOJOL 4:1 for epilepsy
Jolly Healthcare has launched KETOJOL 4:1, a new ketogenic diet formulation for treating Drug-Resistant Epilepsy. This product is designed for clinical nutrition and pediatric neurology use, manufactured under a pharmaceutical license. Clinical studies show Ketogenic Dietary Therapy can reduce seizure frequency by $\ge$50% in 50–60% of refractory epilepsy children. The formulation includes prebiotics like Inulin to improve GI tolerance and palatability for kids. It will first be available in tertiary care hospitals and specialized clinics under medical supervision. 🧠